SCHEMBL9354292

SCHEMBL9354292

CCOC(=O)CNC(=O)CCN(C)C(=O)OC(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.54
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.39
HPGD P15428 1/20 0.38
RECQL P46063 1/20 0.37
CNR2 P34972 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MGAM O43451 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
CTSK P43235 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
HTT P42858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL499027 0.85 SMN1; SMN2 (0.40) GAAALDH1A1TSHRSMN1; SMN2MEN1
SCHEMBL31462534 0.82 GAA (0.41) GAAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL23314765 0.82 RECQL (0.35) GAARECQLCA14HDAC1HDAC2
SCHEMBL5347434 0.81 ALDH1A1 (0.38) GAAALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL14822004 0.79 CYP1A2 (0.44) GAAALDH1A1TSHRSMN1; SMN2L3MBTL1
SCHEMBL755177 0.78 CA14 (0.35) TSHRRECQLMEN1KMT2ACA14
SCHEMBL5655019 0.77 HDAC1 (0.44) GAAALDH1A1TSHRSMN1; SMN2KMT2A
SCHEMBL22303932 0.76 NFKB1 (0.43) GAAALDH1A1MEN1KMT2AMGAM
SCHEMBL15285839 0.75 CTSD (0.39) GAACTSKCA12CA1CA14
SCHEMBL5001089 0.75 CA12 (0.55) GAAALDH1A1SMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1026892-C New amino acid derivatives, process for preparation thereof and pharmaceutical composition comprising same FUJISAWA PHARMACEUTICAL CO (JP) 1994-12-07 CN disclosed
EP-0300189-B1 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-11-02 EP disclosed
US-5223489-A Treatment of ypertension and heart failure UJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-29 US disclosed
US-5142048-A Enzyme inhibitor; carbamoyl group-containing acids FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-08-25 US disclosed
US-4921855-A New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-05-01 US disclosed
EP-0300189-A2 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-25 EP disclosed
CN-1030411-A New amino acid derivatives, its preparation method and contain its pharmaceutical composition FUJISAWA PHARMACEUTICAL CO (JP) 1989-01-18 CN disclosed